Structure-antitumor activity relationships of Aza- and Diaza-Anthracene-2,9,10-Triones and their partially saturated derivativer
dc.contributor.author | Avendaño López, María Carmen | |
dc.contributor.author | López-Alvarado Gutiérrez, María Pilar | |
dc.contributor.author | Pérez, José María | |
dc.contributor.author | Alonso, Miguel Ángel | |
dc.contributor.author | Pascual Alfonso, Eva | |
dc.contributor.author | Ruiz Serrano, Miriam | |
dc.contributor.author | Menéndez Ramos, José Carlos | |
dc.date.accessioned | 2024-05-08T09:37:34Z | |
dc.date.available | 2024-05-08T09:37:34Z | |
dc.date.issued | 2024-01-18 | |
dc.description | 2024 Descuento MDPI | |
dc.description.abstract | The 1,8-Diazaanthracene-2,9,10-triones, their 5,8-dihydro derivatives, and 1,8-diazaanthracene-2,7,9,10-tetraones, structurally related to the diazaquinomycin family of natural products, were synthesized in a regioselective fashion employing Diels-Alder strategies. These libraries were studied for their cytotoxicity in a variety of human cancer cell lines in order to establish structure-activity relationships. From the results obtained, we conclude that some representatives of the 1,8-diazaanthracene-2,9,10-trione framework show potent and selective cytotoxicity against solid tumors. Similar findings were made for the related 1-azaanthracene-2,9,10-trione derivatives, structurally similar to the marcanine natural products, which showed improved activity over their natural counterparts. An enantioselective protocol based on the use of a SAMP-related chiral auxiliary derived was developed for the case of chiral 5-substituted 1,8-diazaanthracene-2,9,10-triones, and showed that their cytotoxicity was not enantiospecific. | |
dc.description.department | Depto. de Química en Ciencias Farmacéuticas | |
dc.description.faculty | Fac. de Farmacia | |
dc.description.fundingtype | Descuento UCM | |
dc.description.refereed | TRUE | |
dc.description.sponsorship | Ministerio de Ciencia e Innovacion | |
dc.description.status | pub | |
dc.identifier.citation | Avendaño C, López-Alvarado P, Pérez JM, Alonso MÁ, Pascual-Alfonso E, Ruiz-Serrano M, et al. Structure-antitumor activity relationships of Aza- and diaza-anthracene-2,9,10-triones and their partially saturated derivatives. Molecules [Internet]. 2024;29(2):489. Available from: http://dx.doi.org/10.3390/molecules29020489 | |
dc.identifier.doi | 10.3390/molecules29020489 | |
dc.identifier.essn | 1420-3049 | |
dc.identifier.officialurl | https://www.mdpi.com/1420-3049/29/2/489 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14352/103802 | |
dc.issue.number | 2 | |
dc.journal.title | Molecules | |
dc.language.iso | eng | |
dc.publisher | MDPI | |
dc.rights | Attribution 4.0 International | en |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject.cdu | 615.011 | |
dc.subject.keyword | Azaanthracene-2,9,10-triones | |
dc.subject.keyword | Diazaanthracene-2,9,10-triones | |
dc.subject.keyword | Hetero Diels–Alder reactions | |
dc.subject.keyword | Antitumor activity | |
dc.subject.keyword | Diazaquinomycins | |
dc.subject.keyword | Marcanines | |
dc.subject.ucm | Química farmaceútica | |
dc.subject.unesco | 2390 Química Farmacéutica | |
dc.title | Structure-antitumor activity relationships of Aza- and Diaza-Anthracene-2,9,10-Triones and their partially saturated derivativer | |
dc.type | journal article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 29 | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 161e45c5-4a3f-4e91-afa9-63f75220dde0 | |
relation.isAuthorOfPublication | 0e2f8c68-6bad-4dfd-90e7-1b6ed4f62a78 | |
relation.isAuthorOfPublication | 4db1d8a4-04dc-4408-a692-c08b5281a87a | |
relation.isAuthorOfPublication | 4c8ca147-677d-4846-97b7-d4419662ff60 | |
relation.isAuthorOfPublication.latestForDiscovery | 161e45c5-4a3f-4e91-afa9-63f75220dde0 |
Download
Original bundle
1 - 1 of 1
Loading...
- Name:
- Structure antitumor activity.pdf
- Size:
- 8.33 MB
- Format:
- Adobe Portable Document Format